批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/03/11 |
SUPPL-73(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/02/12 |
SUPPL-71(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/02/05 |
SUPPL-72(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2019/01/25 |
SUPPL-70(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/07/27 |
SUPPL-68(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/02/23 |
SUPPL-66(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2016/03/01 |
SUPPL-65(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/04/28 |
SUPPL-62(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/08/02 |
SUPPL-53(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2012/03/12 |
SUPPL-55(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/09/24 |
SUPPL-54(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/09/24 |
SUPPL-48(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/08/24 |
SUPPL-47(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/06/15 |
SUPPL-52(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/12/01 |
SUPPL-51(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2010/08/30 |
SUPPL-50(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/08/30 |
SUPPL-49(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/08/30 |
SUPPL-46(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/08/30 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/07/19 |
SUPPL-44(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2008/08/14 |
SUPPL-42(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/08/22 |
SUPPL-37(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2007/08/22 |
SUPPL-36(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2006/10/06 |
SUPPL-29(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2006/10/06 |
SUPPL-28(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2006/10/06 |
SUPPL-24(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2005/08/17 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/12/04 |
SUPPL-18(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2003/12/04 |
SUPPL-17(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2003/11/21 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/10/29 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/09/10 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/11/19 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/03/03 |
SUPPL-4(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2001/10/22 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/07/02 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/10/08 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/06/03 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/05/19 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/04/02 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/10/17 |
SUPPL-2(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
1997/04/15 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/06/10 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:RISPERIDONE 剂型/给药途径:SOLUTION;ORAL 规格:1MG/ML 治疗等效代码:AA
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020588 |
001 |
NDA |
RISPERDAL |
RISPERIDONE |
SOLUTION;ORAL |
1MG/ML |
Prescription |
Yes |
Yes |
AA |
1996/06/10
|
JANSSEN PHARMS |
076904 |
001 |
ANDA |
RISPERIDONE |
RISPERIDONE |
SOLUTION;ORAL |
1MG/ML |
Discontinued |
No |
No |
AA |
2009/07/29
|
HIKMA |
077719 |
001 |
ANDA |
RISPERIDONE |
RISPERIDONE |
SOLUTION;ORAL |
1MG/ML |
Discontinued |
No |
No |
AA |
2009/07/29
|
PHARM ASSOC |
078452 |
001 |
ANDA |
RISPERIDONE |
RISPERIDONE |
SOLUTION;ORAL |
1MG/ML |
Prescription |
No |
No |
AA |
2009/09/04
|
AUROBINDO PHARMA LTD |
079158 |
001 |
ANDA |
RISPERIDONE |
RISPERIDONE |
SOLUTION;ORAL |
1MG/ML |
Prescription |
No |
No |
AA |
2010/12/03
|
LANNETT CO INC |
090347 |
001 |
ANDA |
RISPERIDONE |
RISPERIDONE |
SOLUTION;ORAL |
1MG/ML |
Prescription |
No |
No |
AA |
2011/02/07
|
TARO |
091384 |
001 |
ANDA |
RISPERIDONE |
RISPERIDONE |
SOLUTION;ORAL |
1MG/ML |
Prescription |
No |
No |
AA |
2011/05/25
|
AMNEAL PHARMS |
079059 |
001 |
ANDA |
RISPERIDONE |
RISPERIDONE |
SOLUTION;ORAL |
1MG/ML |
Prescription |
No |
No |
AA |
2012/12/12
|
TRIS PHARMA INC |
202386 |
001 |
ANDA |
RISPERIDONE |
RISPERIDONE |
SOLUTION;ORAL |
1MG/ML |
Prescription |
No |
No |
AA |
2015/01/12
|
CHARTWELL MOLECULAR |